首页> 外国专利> Use of galantamine to treat neuropsychiatric behavior associated with alzheimer's disease

Use of galantamine to treat neuropsychiatric behavior associated with alzheimer's disease

机译:加兰他敏用于治疗与阿尔茨海默氏病有关的神经精神行为的用途

摘要

"USE OF GALANTAMIN FOR TREATMENT OF NEUROPSYCHIATRIC BEHAVIOR ASSOCIATED WITH ALZHEIMER DISEASE". The invention relates to galantamine which has been used in the treatment of a number of chronic diseases. Galantamine has been found to be safe and effective in treating Alzheimer's disease. Neuropsychiatric disorders are often associated with Alzheimer's disease. galantamine is also shown to be effective in reducing or stabilizing the incidence of neuropsychiatric behavior observed in Alzheimer's patients.
机译:“使用加兰他敏治疗与老年痴呆相关的神经性精神行为”。本发明涉及加兰他敏,其已被用于治疗许多慢性疾病。加兰他敏已被发现在治疗阿尔茨海默氏病方面是安全有效的。神经精神疾病通常与阿尔茨海默氏病有关。加兰他敏也显示出有效减少或稳定在阿尔茨海默氏病患者中观察到的神经精神行为的发生率。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号